Table of Contents
Global Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market share, market size (value , and forecast to 2019). The guide also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Features and benefits
* Save time carrying out entry-level research by identifying the size, growth, and leading players in the global pharmaceuticals market
* Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global pharmaceuticals market
* Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
* Add weight to presentations and pitches by understanding the future growth prospects of the global pharmaceuticals market with five year forecasts
The global pharmaceuticals market had total revenue of $866.9bn in 2014, representing a compound annual growth rate (CAGR) of 4.7% between 2010 and 2014.
The US, Japan and China are the very largest markets followed by the four biggest European markets.
The performance of the market is forecast to accelerate, with an anticipated CAGR of 5.8% for the five-year period 2014 - 2019, which is expected to drive the market to a value of $1,147.1bn by the end of 2019.
Your key questions answered
* What was the size of the global pharmaceuticals market by value in 2014?
* What will be the size of the global pharmaceuticals market in 2019?
* What factors are affecting the strength of competition in the global pharmaceuticals market?
* How has the market performed over the last five years?
* Who are the top competitors in the global pharmaceuticals market?
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025 Summary Psoriatic arthritis (PsA) is a chronic immune-mediated arthritis typically affecting the large joints, especially ...
PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2025 Summary Sales of dyslipidemia therapeutics is estimated to be approximately $11.2B across the 7MM in 2015, encompassing the ...
PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...